Skip to main content

Does Kevzara cause weight gain?

Medically reviewed by Carmen Pope, BPharm. Last updated on June 14, 2024.

Official Answer by Drugs.com

Overview

Information

Weight gain has not been reported as a side effect of Kevzara. Common side effects of Kevzara include:

The symptoms of rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), and active polyarticular juvenile idiopathic arthritis (pJIA) can make people tired and make it hard for them to move and exercise, which may contribute to weight gain. Other drugs that may also be given for rheumatoid arthritis or PMR, such as prednisone, are more likely to be the reason behind weight gain.

Related questions

About Kevzara

Kevzara (sarilumab) is used to treat adults with RA or PMR, and patients weighing 63 kg or greater with active pJIA. It belongs to a family of medicines called interleukin-6 (IL-6) inhibitors and is a type of biologic.

References
  • Kevzara (sarilumab) You’ve just started KEVZARA. So what’s ahead? Sanofi Genzyme. https://www.kevzara.com/starting-kevzara/what-to-expect
  • Kevzara (sarilumab) [Package Insert] sanofi-aventis U.S. LLC 06/2024. https://products.sanofi.us/kevzara/kevzara.pdf
  • FDA approves Kevzara for Active Polyarticular Juvenile Idiopathic Arthritis https://www.drugs.com/newdrugs/fda-approves-kevzara-sarilumab-active-polyarticular-juvenile-idiopathic-arthritis-pjia-6292.html

Read next

Is obesity a major risk factor for Covid-19?

Obesity is a major risk factor for covid-19 and people who are obese are more likely than those who are not obese to contract Covid-19 at a younger age, develop severe Covid-19, require hospitalization, oxygen, mechanical ventilation, intubation, or admission into ICU, end up in hospital sooner, or die from Covid-19. Continue reading

Mounjaro vs Ozempic: Which is right for you?

Mounjaro and Ozempic are prescription medicines used alongside diet and exercise to help control blood sugar (glucose) levels in adults with type 2 diabetes. Ozempic is also approved to lower the risk of a major cardiovascular event (like a heart attack or stroke) in patients with type 2 diabetes, as well as to reduce the risk of worsening kidney disease and heart-related death in patients with type 2 diabetes. Mounjaro has not yet received these indications, although studies are ongoing.

In a large, 2024 retrospective study in adults with overweight or obesity and treated for type 2 diabetes, Mounjaro led to at least a 5% weight loss within one year in 81.8% of adults compared to 66.5% of those using Ozempic. Continue reading

Zepbound Vs Mounjaro: Complete Comparison Guide for Weight Loss and Diabetes Treatment

Comprehensive comparison of Zepbound vs Mounjaro. Learn about their uses, dosing, effectiveness, costs, and safety profiles to understand which medication might be right for you. Continue reading

See also:

Related medical questions

Drug information

Related support groups